Seniors have been suffering and dying because high drug prices force them to forgo life-saving medications. The PRICED Act, introduced Thursday by Rep. Jan Schakowsky, Rep. Rosa DeLauro (D-CT), Rep. Angie Craig (D-MN), Rep. Lloyd Doggett (D-TX), Rep. Raja Krishnamoorthi (D-IL) and 11 other cosponsors is a bold step toward lowering prescription drug prices. It would allow generic versions of brand name biologic drugs to enter the market sooner, encouraging competition and driving down costs. It would reverse the current practice of protecting Big Pharma’s profits over the health and financial well-being of patients. Congress should pass the PRICED Act now, as well as allow Medicare to negotiate directly with drug manufacturers and end other kinds of anti-competitive behaviors that keep brand drug prices exorbitantly high. It’s past time for Congress to show Big Pharma that patients must always come before profits. – Max Richtman, President and CEO of the National Committee to Preserve Social Security and Medicare
The National Committee, a nonprofit, nonpartisan organization acts in the interests of its membership through advocacy, education, services, grassroots efforts and the leadership of the Board of Directors and professional staff. The work of the National Committee is directed toward developing better-informed citizens and voters.
Media Inquiries to:
Pamela Causey 202-216-8378/202-236-2123
Walter Gottlieb 202-216-8414